Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. Troriluzole demonstrated a 50-70% slowing of SCA disease progression ...

Melissa Beiner, M.D., SCA Clinical Development Lead at Biohaven, commented, Our NDA filing is the culmination of over 8 years of clinical research a ...

BDNF (200 ng/mL) was used as positive control. Continually ... neuroprotective effects by reducing apoptosis and ROS production, PSM-04 can be a potential pharmacological agent for treating ...

After PSM, the median PFS was 24.8 months in the I-CRT group vs ... Following induction treatment, objective response rates (ORRs) and disease control rates (DCRs) were assessed. PFS was estimated ...

If confirmed, Kennedy would oversee a $1.7 trillion annual budget and 13 agencies, including the National Institutes of Health and the Centers for Disease Control and Prevention. Prior to the ...

Cancer and accidental deaths continue to remain the second and third leading causes of death, respectively, according to the latest data from the Centers for Disease Control and Prevention (CDC).